Last reviewed · How we verify
NCT05245825: LINAPRED
Flaxseed Supplementation in Prediabetic Adults (LINAPRED)
NA trial testing Flaxseed in Prediabetic State in 96 participants. Status unknown.
20 February 2024
Quick facts
| Lead sponsor | Centro Universitario de Ciencias de la Salud, Mexico |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 96 |
| Start date | 20 November 2021 |
| Primary completion | 20 February 2024 |
| Estimated completion | 20 February 2024 |
| Sites | 1 location across Mexico |
Drugs / interventions tested
- Flaxseed — full drug profile →
- Dietary plan
Conditions studied
- Prediabetic State — all drugs for Prediabetic State →
Sponsor
Centro Universitario de Ciencias de la Salud, Mexico — full company profile →
Who can join
Adults 30 to 59, any sex, with Prediabetic State. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Prediabetes is the term used to describe the condition where blood glucose level is higher than normal but lower than the diagnosis criteria of type 2 diabetes mellitus (T2DM). This condition confers a high risk for the development of T2DM and other diseases. Prediabetes could be reversible with lifestyle modifications, which include medical-nutrition therapy. Within these modifications, a healthy diet high in fiber and sources of alpha-linolenic acid is recommended. Flaxseed is a seed that is considered a functional food because it can provide health benefits due to its high content of fiber, alpha-linolenic acid, and lignans, these components could improve glycemic control in prediabetes patients by different mechanisms. The purpose of this study is to assess the effect of flaxseed on glycemic control in prediabetic adults.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05245825
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Flaxseed
Trials testing the same drug.
- NCT07530965 — OMEGA-3-FATTY ACIDS IN CHILDREN WITH SICKLE CELL DISEASE · NA · not yet recruiting
- NCT03915600 — Efect of Quinoa and Flaxseed in Cititoxicity and Glicemic Control in Metabolic Syndrome Patients · NA · unknown
- NCT04024605 — Bioavailability of Protein and Amino Acids From Oilseeds in Healthy Volunteers · NA · unknown
- NCT03183102 — The Role of the Gut Microbiota in Estrogen Metabolism and Dietary Flax as a Potential Modulator. · NA · completed
- NCT03392025 — Flaxseed Consumption, Alone and in Combination With the Mediterranean-like Diet, on Some Indicators Related to Atheroscl · NA · completed
Other recruiting trials for Prediabetic State
Currently open trials in the same condition.
- NCT07403604 — Effect of Insulin Lowering on Lipogenesis · Phase 1 · recruiting
- NCT06897982 — Feasibility of a Nutrition Intervention for Patients With Prediabetes at a Federally Qualified Health Center · NA · recruiting
- NCT06118931 — Time-restricted Eating, Window Timing, Type 2 Diabetes Status and Sex on Glycemic Control · NA · recruiting
- NCT06471569 — Role of Aging and Individual Variation in Exercise Training Responsiveness · NA · recruiting
- NCT06723886 — Antidiabetic Effect of Olive Pomace Oil · NA · recruiting
Other Centro Universitario de Ciencias de la Salud, Mexico trials
Trials by the same sponsor.
- NCT05427721 — Thymol on Netrin-1 on Obese Patients · Phase 2 · unknown
- NCT05403060 — Educational Nutritional Intervention for Adolescents · NA · completed
- NCT05230979 — Evaluation of Common Bean Baked Snack Consumption on Subjective Satiety, Energy Intake and Glycemic Response in People W · Phase 2 · completed
- NCT05089305 — Ozone Plasma on Lung Function and Inflammatory Parameters in Pulmonary Sequelae Associated With Coronavirus 19 Infection · Phase 2 · unknown
- NCT05028699 — Evaluation of Common Bean Baked Snack Consumption on Blood Lipids in Overweight People With Altered Blood Lipid Levels · Phase 2 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05245825 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centro Universitario de Ciencias de la Salud, Mexico
- Last refreshed: 9 February 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05245825.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing